id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-P-0151-0001,FDA,FDA-2000-P-0151,FDA/DDM to Satori Food Corp.,Other,ACK-Acknowledgement Letter,2000-12-29T05:00:00Z,2000,12,,,2008-04-25T01:31:51Z,,0,0,09000064804d117d
FDA-2000-N-0039-0001,FDA,FDA-2000-N-0039,Agency Information Collection Activities; Proposed Collection; Comment Request; Shipment of a Blood Product Prior to Completion of Testing for Hepatitis B Surface Antigen (HBsAg); and Shipment of Blood Products Known Reactive for HBsAg,Notice,General Notice,2000-12-28T05:00:00Z,2000,12,2000-09-07T04:00:00Z,2000-11-07T04:59:59Z,2025-06-12T20:27:59Z,00-22951,0,0,09000064804aeef1
FDA-2000-N-0044-0001,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 3 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:50Z,,0,0,09000064804aefe4
FDA-2000-N-0044-0002,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 1 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:48Z,,0,0,09000064804af000
FDA-2000-M-0122-0001,FDA,FDA-2000-M-0122,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-09T22:50:06Z,00-31960,0,0,09000064804cf359
FDA-2000-M-0123-0001,FDA,FDA-2000-M-0123,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-09T23:30:31Z,00-31960,0,0,09000064804cf3cb
FDA-2000-M-0050-0001,FDA,FDA-2000-M-0050,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2017-09-29T13:19:49Z,00-31960,0,0,09000064804af23a
FDA-2000-P-0210-0001,FDA,FDA-2000-P-0210,Notice of Exemption,Notice,General Notice,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-01-17T04:59:59Z,2024-07-31T15:27:14Z,,0,0,09000064804d4c10
FDA-2000-M-0177-0001,FDA,FDA-2000-M-0177,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-09T23:05:47Z,00-31960,0,0,09000064804d2768
FDA-2000-M-0167-0001,FDA,FDA-2000-M-0167,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-21T23:25:52Z,00-31960,0,0,09000064804d23dd
FDA-2000-M-0178-0001,FDA,FDA-2000-M-0178,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-21T23:15:54Z,00-31960,0,0,09000064804d27c8
FDA-2000-M-0117-0001,FDA,FDA-2000-M-0117,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-21T22:48:43Z,00-31960,0,0,09000064804cf1d7
FDA-2000-M-0019-0001,FDA,FDA-2000-M-0019,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-09T23:38:44Z,00-31960,0,0,09000064804ae968
FDA-2000-N-0044-0003,FDA,FDA-2000-N-0044,Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables - Notice of Proposed Rule (part 2 of 3),Notice,NPR-Notice of Proposed Rule-Making,2000-12-27T05:00:00Z,2000,12,2000-12-27T05:00:00Z,2001-03-23T04:59:59Z,2011-06-11T16:25:49Z,,0,0,09000064804af001
FDA-2000-M-0121-0001,FDA,FDA-2000-M-0121,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-09T22:42:27Z,00-31960,0,0,09000064804cf2f1
FDA-2000-M-0093-0001,FDA,FDA-2000-M-0093,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-12-27T05:00:00Z,2000,12,,,2025-07-11T16:08:10Z,00-31960,0,0,09000064804b81ad
FDA-2000-D-0598-0001,FDA,FDA-2000-D-0598,International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); Draft Guidance for Industry on Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies (VICH GL23); Availability; Request for Comments,Notice,Notice of Data Availability,2000-12-18T05:00:00Z,2000,12,2000-12-18T05:00:00Z,2001-01-18T04:59:59Z,2013-08-11T04:11:06Z,,0,0,09000064804dd8b2
FDA-2000-D-0598-0002,FDA,FDA-2000-D-0598,Guidance for Industry #116 Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies VICH GL23; Draft Guidance,Other,Guidance,2000-12-18T05:00:00Z,2000,12,2013-01-23T05:00:00Z,,2013-01-24T03:08:44Z,,0,0,09000064804dd8b1
FDA-2000-P-0066-0001,FDA,FDA-2000-P-0066,Notice of Final Rule: Medical Device; Exemption From Premarket Notification; Class II Devices; Barium Enema Retention Catheters and Tips With or Without a Bag,Notice,Notice of Final Rule,2000-12-14T05:00:00Z,2000,12,,,2026-01-22T22:35:19Z,,0,0,09000064804afc70
FDA-1997-C-0030-0003,FDA,FDA-1997-C-0030,Listing of Color Additives Exempt From Certification; Luminescent Zinc Sulfide; Correction,Notice,Correction,2000-12-14T05:00:00Z,2000,12,,,2024-12-10T17:56:44Z,,0,0,09000064805ca385
FDA-2000-P-1559-0001,FDA,FDA-2000-P-1559,FDA/DDM to Center for Science in the Public Interest (CSPI),Other,ACK-Acknowledgement Letter,2000-12-13T05:00:00Z,2000,12,,,2008-04-25T01:56:32Z,,0,0,09000064804f9287
FDA-1997-P-0017-0001,FDA,FDA-1997-P-0017,"Food Labeling Safe Handling Statements,Labeling of Shell Eggs; Refrigeration of Shell Eggs Held for Retail Distribution; Notice of Final Rule",Notice,NFR-Notice of Final Rule,2000-12-06T05:00:00Z,2000,12,,,2015-05-20T15:06:16Z,,0,0,09000064805c9c5f
FDA-1991-F-0007-0001,FDA,FDA-1991-F-0007,FDA,Notice,NWL-Notice of Withdrawl,2000-12-05T05:00:00Z,2000,12,,,2008-05-16T23:37:54Z,,0,0,0900006480525a52
FDA-1994-P-0041-0003,FDA,FDA-1994-P-0041,FDA,Notice,NEC-Notice of Extension,2000-12-05T05:00:00Z,2000,12,2000-12-05T05:00:00Z,2001-01-20T04:59:59Z,2008-05-16T23:20:38Z,,0,0,09000064804feb07
FDA-2000-F-0115-0001,FDA,FDA-2000-F-0115,"[Docket Nos. 821;-0349,90F-0188,91F-0169,93F-0157,93F-0199,95F-0011,96F-0032, 96F-
0223,98F-0226,98F-0288,98F-0289,99F-0052,99F-0460,99F-1074,99F-2244,99F-2245,
99F-50 12, and OOF-00891",Notice,Withdrawal,2000-12-05T00:00:00Z,2000,12,,,2025-05-21T19:30:55Z,,0,0,09000064804cf0fa
FDA-2000-D-0028-0002,FDA,FDA-2000-D-0028,Guidance for Industry: Channels of Trade Policy for Commodities with Methyl Parathion Residues,Other,Guidance,2000-11-30T05:00:00Z,2000,11,2020-09-30T04:00:00Z,,2024-11-12T23:25:43Z,,1,0,09000064848a2c00
FDA-2000-D-0105-0001,FDA,FDA-2000-D-0105,FDA,Notice,NAD-Notice of Availability of Data,2000-11-22T05:00:00Z,2000,11,2000-11-22T05:00:00Z,2001-02-13T04:59:59Z,2008-04-25T01:32:13Z,,0,0,09000064804c248f
FDA-1999-D-0044-0001,FDA,FDA-1999-D-0044,FDA,Notice,NAD-Notice of Availability of Data,2000-11-22T05:00:00Z,2000,11,2000-11-22T05:00:00Z,2001-02-13T04:59:59Z,2018-08-15T01:04:10Z,,0,0,09000064804a5f4d
FDA-1997-D-0009-0004,FDA,FDA-1997-D-0009,Recognition List Number 004,Notice,NAD-Notice of Availability of Data,2000-11-15T05:00:00Z,2000,11,,,2008-05-16T21:59:17Z,,0,0,09000064805c9a39
FDA-2000-D-0100-0001,FDA,FDA-2000-D-0100,FDA,Notice,NAD-Notice of Availability of Data,2000-11-11T05:00:00Z,2000,11,2000-11-11T05:00:00Z,2001-01-09T04:59:59Z,2008-04-25T01:47:25Z,,0,0,09000064804c214d
FDA-2000-N-0143-0001,FDA,FDA-2000-N-0143,"Applications for FDA Approval to Market a New Drug; Proposed Revision of Postmarketing Reporting
Requirements",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-11-08T05:00:00Z,2000,11,2000-11-07T05:00:00Z,2001-02-06T04:59:59Z,2025-06-13T00:25:01Z,00-28519,0,0,09000064804d0dc5
FDA-1998-P-0046-0001,FDA,FDA-1998-P-0046,FDA/CDRH to Arnold Levin,Other,PDN-Petition Denial,2000-11-08T05:00:00Z,2000,11,,,2008-05-16T21:47:38Z,,0,0,090000648056e6a9
FDA-2000-P-0212-0001,FDA,FDA-2000-P-0212,New Jersey General Assembly - Citizen Petition,Other,CP-Citizen Petition,2000-11-06T05:00:00Z,2000,11,,,2010-08-12T19:47:56Z,,0,0,09000064804d4d1b
FDA-2000-N-0109-0001,FDA,FDA-2000-N-0109,Enrofloxacin for Poultry; Opportunity for Hearing,Notice,Notice of Opportunity of Hearing,2000-11-02T05:00:00Z,2000,11,2000-11-02T05:00:00Z,2001-01-03T04:59:59Z,2025-09-04T15:27:34Z,00-27832,0,0,09000064804c2a0d
FDA-1999-F-0021-0002,FDA,FDA-1999-F-0021,"Irradiation in the Production, Processing and Handling of Food; Notice of Final Rule",Notice,NFR-Notice of Final Rule,2000-11-01T05:00:00Z,2000,11,2000-11-01T05:00:00Z,2000-11-30T04:59:59Z,2011-07-20T15:50:56Z,,0,0,09000064804a5aca
FDA-2000-P-0025-0003,FDA,FDA-2000-P-0025,Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association,Other,PAV-Petition Approval,2000-10-31T05:00:00Z,2000,10,,,2024-07-29T20:17:20Z,,0,0,09000064804aea11
FDA-2000-P-0025-0002,FDA,FDA-2000-P-0025,Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association,Other,PAV-Petition Approval,2000-10-31T05:00:00Z,2000,10,,,2024-07-29T20:14:37Z,,0,0,09000064804aea10
FDA-1999-D-0081-0002,FDA,FDA-1999-D-0081,"""Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;"" Availability",Notice,Notice of Data Availability,2000-10-24T04:00:00Z,2000,10,,,2025-07-01T21:48:06Z,00-26670,0,0,09000064804a6961
FDA-2000-N-0072-0001,FDA,FDA-2000-N-0072,"Medical Devices; Labeling for Menstrual Tampons; Ranges of Absorbency, Change From ‘‘Junior’’ to ‘‘Light’’",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-10-24T04:00:00Z,2000,10,2000-10-18T04:00:00Z,2001-01-17T04:59:59Z,2025-06-13T00:08:59Z,00–26249,0,0,09000064804b0271
FDA-2000-P-0153-0001,FDA,FDA-2000-P-0153,"FDA/DDM to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2000-10-16T04:00:00Z,2000,10,,,2008-04-25T01:45:52Z,,0,0,09000064804d1408
FDA-2000-D-0028-0001,FDA,FDA-2000-D-0028,"Draft Guidance for Industry: Channels of Trade Policy for Commodities With Methyl
Parathion Residues; Availability",Notice,Notice of Availability,2000-10-16T04:00:00Z,2000,10,2000-10-16T04:00:00Z,2000-12-07T04:59:59Z,2021-11-12T16:00:23Z,,0,0,09000064804aeb11
FDA-1997-C-0051-0002,FDA,FDA-1997-C-0051,Listing of Color Additives Exempt from Certification; Phaffia Yeast; Confirmation of Effective Date,Notice,Notice of Confirmation of Effective Date,2000-10-16T04:00:00Z,2000,10,,,2024-11-25T15:30:11Z,00-25704,0,0,09000064805cfcf5
FDA-1991-F-0028-0001,FDA,FDA-1991-F-0028,W.R. Grace & Co.; Withdrawal of Food Additive Petition,Notice,Withdrawal,2000-10-16T04:00:00Z,2000,10,,,2023-08-09T18:20:00Z,,0,0,0900006480528968
FDA-1997-C-0030-0002,FDA,FDA-1997-C-0030,Listing of Color Additives Exempt From Certification; Luminescent Zinc Sulfide; Confirmation of Effective Date,Notice,Notice of Confirmation of Effective Date,2000-10-16T04:00:00Z,2000,10,,,2024-12-10T17:54:10Z,,0,0,09000064805ca384
FDA-1991-N-0043-0016,FDA,FDA-1991-N-0043,FDA,Notice,N-Notice,2000-10-11T04:00:00Z,2000,10,,,2008-05-16T23:40:52Z,,0,0,090000648052af62
FDA-1991-N-0033-0017,FDA,FDA-1991-N-0033,FDA,Notice,N-Notice,2000-10-11T04:00:00Z,2000,10,,,2008-05-16T23:40:27Z,,0,0,09000064805297be
FDA-1999-N-0035-0002,FDA,FDA-1999-N-0035,Jay Marcus; Debarment Order,Notice,Statutory Debarment,2000-10-03T04:00:00Z,2000,10,,,2024-10-21T20:24:44Z,00–25086,0,0,09000064804a5d4b
FDA-1994-N-0026-0002,FDA,FDA-1994-N-0026,Rami Elsharaiha; Debarment Order,Notice,Statutory Debarment,2000-10-03T04:00:00Z,2000,10,,,2024-06-10T15:11:58Z,00–25087,0,0,09000064804fd2cc
FDA-1991-N-0043-0015,FDA,FDA-1991-N-0043,FDA,Notice,NFR-Notice of Final Rule,2000-10-03T04:00:00Z,2000,10,,,2008-05-16T23:40:52Z,,0,0,090000648052af5b
FDA-1994-N-0052-0001,FDA,FDA-1994-N-0052,Mohammad Uddin; Debarment Order,Notice,Statutory Debarment,2000-10-03T04:00:00Z,2000,10,,,2024-06-17T13:04:12Z,00-25088,0,0,09000064805037b6
FDA-1991-N-0033-0016,FDA,FDA-1991-N-0033,FDA,Notice,NFR-Notice of Final Rule,2000-10-03T04:00:00Z,2000,10,,,2008-05-16T23:40:18Z,,0,0,090000648052979b
FDA-2000-P-0096-0002,FDA,FDA-2000-P-0096,FDA/DDM to Arnold & Porter,Other,ACK-Acknowledgement Letter,2000-10-02T04:00:00Z,2000,10,,,2008-04-25T01:01:16Z,,0,0,09000064804b8220
FDA-2000-P-0096-0001,FDA,FDA-2000-P-0096,FDA/DDM to Arnold & Porter,Other,ACK-Acknowledgement Letter,2000-10-02T04:00:00Z,2000,10,,,2008-04-25T01:01:17Z,,0,0,09000064804b8209
FDA-2000-N-0107-0001,FDA,FDA-2000-N-0107,Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs,Notice,General Notice,2000-09-25T04:00:00Z,2000,9,2000-09-19T04:00:00Z,2000-11-21T04:59:59Z,2025-06-12T21:09:55Z,00-23886,0,0,09000064804c25d8
FDA-2000-N-0142-0002,FDA,FDA-2000-N-0142,Notice of Proposed Rule re Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-09-25T04:00:00Z,2000,9,2000-09-25T04:00:00Z,2000-12-05T04:59:59Z,2015-05-14T14:36:10Z,,0,0,09000064804d0d36
FDA-2000-N-0005-0003,FDA,FDA-2000-N-0005,FDA,Notice,NAL-Notice of Approval,2000-09-25T04:00:00Z,2000,9,,,2008-04-25T00:52:11Z,,0,0,09000064804ae619
FDA-1992-N-0056-0005,FDA,FDA-1992-N-0056,"Notice of Hearing Before Commissioner re Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements, and Administration Procedures; Public Hearing",Notice,Notice of Pre-Hearing Conference,2000-09-25T04:00:00Z,2000,9,2000-09-25T04:00:00Z,2000-11-21T04:59:59Z,2016-10-13T16:04:54Z,,0,0,090000648052bf6e
FDA-2000-N-0142-0001,FDA,FDA-2000-N-0142,Notice of Proposed Rule Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-09-25T04:00:00Z,2000,9,2000-09-19T04:00:00Z,2000-12-05T04:59:59Z,2015-05-14T14:12:46Z,,0,0,09000064804d0d1e
FDA-2000-N-0078-0001,FDA,FDA-2000-N-0078,Agency Information Collection Activities: Proposed Collection; Comment Request; Extension; Threshold of Regulation for Substances Used in Food-Contact Articles,Notice,General Notice,2000-09-25T04:00:00Z,2000,9,2000-09-19T04:00:00Z,2000-11-21T04:59:59Z,2025-06-12T20:47:00Z,00-23884,0,0,09000064804b7e69
FDA-1997-N-0049-0001,FDA,FDA-1997-N-0049,Agency Information Collection Activities; Proposed Collection; Comment Request; Petition for Administrative Stay of Action,Notice,General Notice,2000-09-25T00:00:00Z,2000,9,2000-09-25T04:00:00Z,2000-11-25T04:59:59Z,2025-05-16T00:13:21Z,00-24537,0,0,09000064805cfcd5
FDA-2000-N-0071-0002,FDA,FDA-2000-N-0071,Medical Devices; CLIA Waiver Criteria; Public Workshop,Notice,Notice of Extension,2000-09-22T04:00:00Z,2000,9,2000-09-15T04:00:00Z,2000-10-17T03:59:59Z,2025-06-06T23:16:46Z,00-23881,0,0,09000064804b0260
FDA-2000-N-0077-0001,FDA,FDA-2000-N-0077,Agency Information Collection Activities; Proposed Collection; Comment Request; Sterility Requirements for Aqueous-Based Drug Products for Oral Inhalation,Notice,General Notice,2000-09-20T04:00:00Z,2000,9,2000-09-18T04:00:00Z,2000-11-18T04:59:59Z,2025-06-12T20:34:09Z,00-23890,0,0,09000064804b7e4f
FDA-2000-N-0164-0002,FDA,FDA-2000-N-0164,HFS-822,Notice,NEC-Notice of Extension,2000-09-20T04:00:00Z,2000,9,2000-09-20T04:00:00Z,2000-11-21T04:59:59Z,2008-04-25T01:16:45Z,,0,0,09000064804d20ff
FDA-2000-N-0228-0003,FDA,FDA-2000-N-0228,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Food Safety Survey; Correction,Notice,Correction,2000-09-20T04:00:00Z,2000,9,2000-09-18T04:00:00Z,,2025-06-05T15:59:59Z,00-23885,0,0,09000064804d55cb
FDA-1994-N-0026-0001,FDA,FDA-1994-N-0026,Rami Elsharaiha; Proposal to Debar; Opportunity for a Hearing,Notice,Notice of Opportunity of Hearing,2000-09-14T04:00:00Z,2000,9,,,2024-06-10T15:12:27Z,99-1034,0,0,09000064804fd2c3
FDA-2000-P-0102-0002,FDA,FDA-2000-P-0102,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:47:38Z,,0,0,09000064804c22b6
FDA-2000-P-0102-0003,FDA,FDA-2000-P-0102,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:47:39Z,,0,0,09000064804c22b7
FDA-2000-P-0133-0003,FDA,FDA-2000-P-0133,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:16:05Z,,0,0,09000064804cfd10
FDA-2000-F-0014-0001,FDA,FDA-2000-F-0014,Alcide Corp.,Notice,NFL-Notice of Filing,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-10-12T03:59:59Z,2008-04-25T01:13:42Z,,0,0,09000064804ae901
FDA-2000-D-0029-0001,FDA,FDA-2000-D-0029,FDA,Notice,NAD-Notice of Availability of Data,2000-09-14T04:00:00Z,2000,9,2000-09-08T04:00:00Z,2000-12-08T04:59:59Z,2008-04-25T01:01:33Z,,0,0,09000064804aeb36
FDA-2000-P-0133-0002,FDA,FDA-2000-P-0133,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:16:04Z,,0,0,09000064804cfd0b
FDA-2000-F-0084-0002,FDA,FDA-2000-F-0084,FDA,Notice,NFL-Notice of Filing,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-10-12T03:59:59Z,2008-04-25T01:01:22Z,,0,0,09000064804b8097
FDA-2000-P-0102-0001,FDA,FDA-2000-P-0102,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:47:38Z,,0,0,09000064804c22ac
FDA-2000-N-0076-0003,FDA,FDA-2000-N-0076,"Activities; Announcement of OMB Approval; Investigational Device Exemptions, Reports, and Records",Notice,Notice of Approval,2000-09-14T04:00:00Z,2000,9,2000-09-12T04:00:00Z,,2025-06-04T23:39:04Z,00-23327,0,0,09000064804b7e3a
FDA-2000-N-0007-0001,FDA,FDA-2000-N-0007,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Export of
Medical Devices-Foreign Letters of Approval",Notice,General Notice,2000-09-14T04:00:00Z,2000,9,2000-09-12T04:00:00Z,2000-10-13T03:59:59Z,2025-06-05T23:55:14Z,00-23326,0,0,09000064804ae662
FDA-2000-P-0133-0001,FDA,FDA-2000-P-0133,FDA,Notice,NIR-Notice of Interim Rule,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-11-23T04:59:59Z,2008-04-25T01:16:04Z,,0,0,09000064804cfc48
FDA-2000-F-0084-0001,FDA,FDA-2000-F-0084,FDA,Notice,NFL-Notice of Filing,2000-09-14T04:00:00Z,2000,9,2000-09-14T04:00:00Z,2000-10-12T03:59:59Z,2008-04-25T01:01:22Z,,0,0,09000064804b807e
FDA-2000-F-0147-0001,FDA,FDA-2000-F-0147,"Electric Power Research Institute, Agriculture and Food
Technology Alliance; Filing of Food Additive Petition",Notice,Notice of Filing,2000-09-13T04:00:00Z,2000,9,,,2025-08-06T21:39:45Z,,0,0,09000064804d0fb2
FDA-2000-D-0159-0001,FDA,FDA-2000-D-0159,FDA,Notice,NAD-Notice of Availability of Data,2000-09-12T04:00:00Z,2000,9,,,2008-04-25T01:16:07Z,,0,0,09000064804d17eb
FDA-2000-N-0012-0003,FDA,FDA-2000-N-0012,Agency Information Collection Activities; Announcement of OMB Approval; Request for Samples and Protocols,Notice,Notice of Approval,2000-09-12T04:00:00Z,2000,9,2000-09-07T04:00:00Z,,2025-06-04T23:18:45Z,00-22850,0,0,09000064804ae8bf
FDA-2000-N-0139-0001,FDA,FDA-2000-N-0139,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Changes to an Approved NDA or ANDA,Notice,General Notice,2000-09-12T04:00:00Z,2000,9,2000-09-07T04:00:00Z,2000-11-07T04:59:59Z,2025-06-12T20:06:56Z,00-22948,0,0,09000064804d0b88
FDA-2000-M-0237-0001,FDA,FDA-2000-M-0237,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-27T21:20:58Z,00-22700,0,0,09000064804d5932
FDA-2000-P-0184-0001,FDA,FDA-2000-P-0184,FDA,Notice,N-Notice,2000-09-07T04:00:00Z,2000,9,2000-09-07T04:00:00Z,2000-10-07T03:59:59Z,2009-04-03T15:16:25Z,,0,0,09000064804d2ab5
FDA-2000-M-0058-0001,FDA,FDA-2000-M-0058,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-26T23:32:17Z,00-22700,0,0,09000064804af5ac
FDA-2000-M-0232-0001,FDA,FDA-2000-M-0232,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-27T22:25:20Z,00-22700,0,0,09000064804d5736
FDA-2000-M-0231-0001,FDA,FDA-2000-M-0231,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-26T22:57:21Z,00-22700,0,0,09000064804d56d7
FDA-2000-M-0090-0001,FDA,FDA-2000-M-0090,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-25T22:49:37Z,00-22700,0,0,09000064804b8156
FDA-2000-M-0235-0001,FDA,FDA-2000-M-0235,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,NAD-Notice of Availability of Data,2000-09-07T04:00:00Z,2000,9,,,2008-11-06T16:37:24Z,,0,0,09000064804d5854
FDA-2000-M-0086-0001,FDA,FDA-2000-M-0086,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-26T22:39:12Z,00-22700,0,0,09000064804b80e4
FDA-2000-M-0176-0001,FDA,FDA-2000-M-0176,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-27T21:53:40Z,00-22700,0,0,09000064804d26fa
FDA-2000-M-0091-0001,FDA,FDA-2000-M-0091,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-26T21:57:16Z,00-22700,0,0,09000064804b8173
FDA-2000-M-0204-0001,FDA,FDA-2000-M-0204,Medical Devices; Availability of Safety and Effectiveness Summaries for PMA,Notice,Notice of Data Availability,2000-09-07T04:00:00Z,2000,9,,,2025-06-25T23:38:09Z,00-22700,0,0,09000064804d4a59
FDA-1998-N-0041-0006,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Service Act; Implementation of Biologics License; Elimination of Establishment License and Product License; Technical Amendment,Notice,Notice of Final Rule,2000-09-06T04:00:00Z,2000,9,,,2026-01-30T22:48:35Z,,0,0,090000648056e5b2
FDA-2000-D-0195-0001,FDA,FDA-2000-D-0195,HFD-210 & HFM-40,Notice,NAD-Notice of Availability of Data,2000-09-01T04:00:00Z,2000,9,2000-09-01T04:00:00Z,2000-11-09T04:59:59Z,2008-04-25T01:14:14Z,,0,0,09000064804d44d0
FDA-2000-N-0158-0001,FDA,FDA-2000-N-0158,Physical Medicine Devices; Revision of the Identification of the Ionotophoresis Device,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-09-01T04:00:00Z,2000,9,2000-08-22T04:00:00Z,2000-11-21T04:59:59Z,2025-06-11T23:53:28Z,00-21251,0,0,09000064804d1701
FDA-1995-N-0030-0001,FDA,FDA-1995-N-0030,Substances Approved for Use in the Preparation of Meat and Poultry Products,Notice,Notice of Final Rule,2000-08-28T04:00:00Z,2000,8,2000-08-25T04:00:00Z,2000-10-25T03:59:59Z,2024-08-12T12:59:50Z,00-21693,0,0,090000648055a5e9
FDA-2000-N-0043-0001,FDA,FDA-2000-N-0043,Presubmission Conferences; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-08-28T04:00:00Z,2000,8,2000-08-25T04:00:00Z,2000-11-09T04:59:59Z,2025-06-11T23:17:01Z,00-21692,0,0,09000064804aefc3
FDA-2000-N-0043-0002,FDA,FDA-2000-N-0043,Presubmission Conferences; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2000-08-28T04:00:00Z,2000,8,2000-08-25T04:00:00Z,2000-11-09T04:59:59Z,2025-06-11T23:17:59Z,00-21692,0,0,09000064804aefc7
FDA-1993-F-0053-0001,FDA,FDA-1993-F-0053,Cognis Corporation; Withdrawal of Food Additive Petition,Notice,Withdrawal,2000-08-25T04:00:00Z,2000,8,,,2024-05-03T13:25:43Z,,0,0,09000064804fc5be
FDA-2000-N-0228-0002,FDA,FDA-2000-N-0228,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Food Safety Survey,Notice,General Notice,2000-08-25T04:00:00Z,2000,8,2000-08-18T04:00:00Z,2000-09-19T03:59:59Z,2025-06-05T15:58:08Z,00-21007,0,0,09000064804d55ca